Improving patient access to biomarker-targeted cancer trials
Overcoming Challenges Posed by Biomarker-Selective Clinical Trials: The Role of a Research Specialist
This study is working to make it easier for cancer patients, especially those from minority and underserved groups, to find and join clinical trials that match their specific needs, by using a special registry and helping doctors identify eligible patients while also teaching everyone about the importance of biomarkers in their treatment.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Johns Hopkins University NIH-funded |
| Lab location | 1 site (Baltimore, United States) |
| Project ID | NIH-11044145 on NIH RePORTER |
What this research studies
This research aims to enhance the identification and enrollment of patients in biomarker-selective clinical trials, which are crucial for advancing cancer treatment. It focuses on creating a molecular registry to streamline patient eligibility determination and using electronic medical records to alert physicians about eligible patients. Additionally, the project emphasizes educating patients about the importance of biomarkers in their treatment options, particularly targeting minority and underserved populations who may face barriers to participation.
Who could benefit from this research
Good fit: Ideal candidates for this research include cancer patients who may benefit from biomarker-targeted therapies and those who are part of minority or underserved populations.
Not a fit: Patients who do not have cancer or those whose conditions do not involve biomarker-targeted therapies may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved access to cutting-edge cancer therapies for patients, particularly those from underserved communities.
How similar studies have performed: Previous research has shown success in improving clinical trial enrollment through similar approaches, particularly in enhancing access for underrepresented populations.
Where this research is happening
Baltimore, United States
- Johns Hopkins University — Baltimore, United States (Active)
Researchers
- Principal investigator: Gaillard, Stephanie — Johns Hopkins University
- Study coordinator: Gaillard, Stephanie
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.